Somnaceutics Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Somnaceutics General Information

Description

Provider of a milk-based sleep tonic in Taiwan. The company offers a tonic made from the milk of cows carrying specific peptides, for sleep-enhancement in humans.

Contact Information

Formerly Known As
Sleep
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Food Products
Primary Office
  • Level 5, Ballantyne House
  • 101 Customs Street East
  • Auckland, 1010
  • New Zealand
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Somnaceutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 07-Dec-2010 00000 Completed Startup
3. Early Stage VC (Series B) 01-Aug-2010 00000 00000 Completed Startup
2. Convertible Debt 11-Jun-2009 $332K $332K Completed Startup
1. Grant $93.1K Completed Startup
To view Somnaceutics’s complete valuation and funding history, request access »

Somnaceutics Executive Team (3)

Name Title Board Seat Contact Info
Bob Elliott Elliot Founding Scientist, Director & Co-Founder
Brent Ogilvie Founding Chief Executive Officer, Director & Co-Founder
You’re viewing 2 of 3 executive team members. Get the full list »

Somnaceutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elevate NZ Venture Fund Fund of Funds Minority 000 0000 000000 0
Pacific Channel Venture Capital Minority 000 0000 000000 0
To view Somnaceutics’s complete investors history, request access »